Filing Details
- Accession Number:
- 0001628280-25-005688
- Form Type:
- 13G Filing
- Publication Date:
- 2025-02-13 19:00:00
- Filed By:
- Austin Che
- Company:
- Ginkgo Bioworks Holdings Inc.
- Filing Date:
- 2025-02-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
---|---|---|---|
Austin Che | 0 | 2,372,573 | 5.0% |
Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 4)
|
Ginkgo Bioworks Holdings, Inc. (Name of Issuer) |
Class A Common Stock (Title of Class of Securities) |
37611X209 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | 37611X209 |
1 | Names of Reporting Persons
Austin Che | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,372,573.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
5.0 % | ||||||||
12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: This Amendment No. 4 (the "Amendment") is being filed to report that the Reporting Person has ceased to be the beneficial owner of more than five percent of the outstanding shares of Class A Common Stock of the Issuer. This Amendment constitutes an exit filing for the Reporting Person.
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
Ginkgo Bioworks Holdings, Inc. | |
(b) | Address of issuer's principal executive offices:
27 Drydock Avenue, 8th Floor, Boston, MA, 02210 | |
Item 2. | ||
(a) | Name of person filing:
Austin Che (the "Reporting Person"). | |
(b) | Address or principal business office or, if none, residence:
The business address of the Reporting Person is c/o Ginkgo Bioworks Holdings, Inc., 27 Drydock Avenue, 8th Floor, Boston, MA 02210. | |
(c) | Citizenship:
The Reporting Person is a citizen of the United States. | |
(d) | Title of class of securities:
Class A Common Stock | |
(e) | CUSIP No.:
37611X209 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
The ownership information presented below represents beneficial ownership of Class A Common Stock of the Issuer as of December 31, 2024, based upon 45,575,423 shares of Class A Common Stock outstanding as of December 31, 2024, and 2,003,679 shares of Class A Common Stock issuable upon conversion of shares of Class B common stock, $0.0001 per share ("Class B Common Stock") beneficially owned by the Reporting Person.
2,372,573 | |
(b) | Percent of class:
5.0% | |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
2,372,573 | ||
(ii) Shared power to vote or to direct the vote:
0 | ||
(iii) Sole power to dispose or to direct the disposition of:
2,372,573 | ||
(iv) Shared power to dispose or to direct the disposition of:
0
The share amount reported herein consists of (i) 318,894 shares of Class A Common Stock of the Issuer held of record by the Reporting Person; (ii) 25,000 shares of Class A Common Stock of the Issuer held of record by a revocable spousal trust, of which the Reporting Person may be deemed to hold investment and voting discretion; (iii) 25,000 shares of Class A Common Stock of the Issuer held of record by a family trust, of which the Reporting Person may be deemed to hold investment and voting discretion; (iv) 1,923,175 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock of the Issuer held of record by the Austin Che Revocable Trust, of which the Reporting Person is the sole trustee; (v) 20,555 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock held of record by the Austin Che Irrevocable Trust, of which the Reporting Person may be deemed to hold investment and voting discretion; (vi) 1,944 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock held of record by an irrevocable marital trust, of which the Reporting Person may be deemed to hold investment and voting discretion; and (vii) 58,005 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock of the Issuer held of record by the Reporting Person. The shares of Class B Common Stock may be redeemed by the holder at any time for shares of Class A Common Stock on a one-to-one basis. | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
![]() | ||
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|